Literature DB >> 11809805

Atypical protein kinase Cs are the Ras effectors that mediate repression of myogenic satellite cell differentiation.

Yuri V Fedorov1, Nathan C Jones, Bradley B Olwin.   

Abstract

Oncogenic Ha-Ras is a potent inhibitor of skeletal muscle cell differentiation, yet the Ras effector mediating this process remains unidentified. Here we demonstrate that the atypical protein kinases (aPKCs; lambda and/or zeta) are downstream Ras effectors responsible for Ras-dependent inhibition of myogenic differentiation in a satellite cell line. First, ectopic expression of Ha-RasG12V induces translocation of PKClambda from the cytosol to the nucleus, suggesting that aPKCs are activated by Ras in myoblasts. The aPKCs function as downstream Ras effectors since inhibition of aPKCs by expression of a dominant negative PKCzeta mutant or by treatment of cells with an inhibitor, GO6983, promotes myogenesis in skeletal muscle satellite cells expressing oncogenic Ha-Ras. Arresting cell proliferation synergistically enhances myogenic differentiation only when aPKCs are also inhibited. Thus, the repression of myogenic differentiation in a satellite cell line appears to be directly mediated by aPKCs acting as Ras effectors and indirectly mediated via stimulation of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809805      PMCID: PMC134628          DOI: 10.1128/MCB.22.4.1140-1149.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes.

Authors:  M Gschwendt; S Dieterich; J Rennecke; W Kittstein; H J Mueller; F J Johannes
Journal:  FEBS Lett       Date:  1996-08-26       Impact factor: 4.124

2.  Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta.

Authors:  M T Diaz-Meco; J Lozano; M M Municio; E Berra; S Frutos; L Sanz; J Moscat
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

3.  Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.

Authors:  R Khosravi-Far; M A White; J K Westwick; P A Solski; M Chrzanowska-Wodnicka; L Van Aelst; M H Wigler; C J Der
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

4.  Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis.

Authors:  M B Ramocki; S E Johnson; M A White; C L Ashendel; S F Konieczny; E J Taparowsky
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways.

Authors:  A J Kudla; M L John; D F Bowen-Pope; B Rainish; B B Olwin
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

6.  MEKK1 binds directly to the c-Jun N-terminal kinases/stress-activated protein kinases.

Authors:  S Xu; M H Cobb
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

7.  A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis.

Authors:  M B Ramocki; M A White; S F Konieczny; E J Taparowsky
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

8.  Overexpression of mammalian protein kinase C-zeta does not affect the growth characteristics of NIH 3T3 cells.

Authors:  P Crespo; H Mischak; J S Gutkind
Journal:  Biochem Biophys Res Commun       Date:  1995-08-04       Impact factor: 3.575

9.  Multiple Ras functions can contribute to mammalian cell transformation.

Authors:  M A White; C Nicolette; A Minden; A Polverino; L Van Aelst; M Karin; M H Wigler
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

10.  The FGF receptor-1 tyrosine kinase domain regulates myogenesis but is not sufficient to stimulate proliferation.

Authors:  A J Kudla; N C Jones; R S Rosenthal; K Arthur; K L Clase; B B Olwin
Journal:  J Cell Biol       Date:  1998-07-13       Impact factor: 10.539

View more
  7 in total

1.  Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes.

Authors:  Mariana M Belcheva; Amy L Clark; Paul D Haas; Jannie S Serna; Jason W Hahn; Alexi Kiss; Carmine J Coscia
Journal:  J Biol Chem       Date:  2005-06-08       Impact factor: 5.157

2.  C-Met expression and mechanical activation of satellite cells on cultured muscle fibers.

Authors:  Ashley C Wozniak; Orest Pilipowicz; Zipora Yablonka-Reuveni; Steven Greenway; Shauna Craven; Elliott Scott; Judy E Anderson
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

Review 3.  Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium.

Authors:  D Breitkreutz; L Braiman-Wiksman; N Daum; M F Denning; T Tennenbaum
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-28       Impact factor: 4.553

4.  Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1).

Authors:  Wei Guo; Shuhong Wu; Li Wang; Rui-yu Wang; Xiaoli Wei; Jinsong Liu; Bingliang Fang
Journal:  Mol Cancer Ther       Date:  2009-02-10       Impact factor: 6.261

5.  TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding.

Authors:  Masakiyo Sakaguchi; Hitoshi Murata; Ken-ichi Yamamoto; Tomoyuki Ono; Yoshihiko Sakaguchi; Akira Motoyama; Toshihiko Hibino; Ken Kataoka; Nam-ho Huh
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

6.  The p38alpha/beta MAPK functions as a molecular switch to activate the quiescent satellite cell.

Authors:  Nathan C Jones; Kristina J Tyner; Lisa Nibarger; Heather M Stanley; Dawn D W Cornelison; Yuri V Fedorov; Bradley B Olwin
Journal:  J Cell Biol       Date:  2005-04-11       Impact factor: 10.539

7.  Inhibition of protein kinase C activity inhibits osteosarcoma metastasis.

Authors:  He-Jun Hu; Xiong-Wei Deng; Run-Xiang Li; De-Wang Chen; Chao Xue
Journal:  Arch Med Sci       Date:  2018-11-07       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.